Biogen (BIIB) PT Lowered to $159 at Bernstein, Reflecting Lowered 2025 Revenue Estimate
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering lowered the price target on Biogen (NASDAQ: BIIB) to $159.00 (from $160.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
